The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA takes first step in possible reversal of ban on some peptides The Washington Post The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Omar Rahman, MD, MBA LA Orthopedic Surgeon Peptides in Orthopedics: Real Potential, Real Questions Peptides have entered the orthopedic conversationnot as shortcuts or miracle Instagram